Search Results - Kin‐Hung P. Yu

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients

    Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients by Anatole Besarab, Robert Provenzano, Joachim Hertel, Raja I. Zabaneh, Stephen J. Klaus, Tyson Lee, Robert Leong, Stefan Hemmerich, Kin-Hung P. Yu, Thomas B. Neff

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Roxadustat for the treatment of anemia in patients with <scp>lower‐risk</scp> myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study

    Roxadustat for the treatment of anemia in patients with <scp>lower‐risk</scp> myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study by David H. Henry, John A. Glaspy, Rosemary Harrup, Moshe Mittelman, Amy Zhou, Hetty E. Carraway, Charles W. Bradley, Gopal Saha, Katharina Modelska, Pamela Bartels, Robert Leong, Kin‐Hung P. Yu

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Roxadustat (FG-4592)

    Roxadustat (FG-4592) by Anatole Besarab, Elena Chernyavskaya, Igor Motylev, Evgeny Shutov, Lalathaksha Kumbar, Konstantin Gurevich, Tak Mao Chan, Robert Leong, Lona Poole, Ming Zhong, Khalil G. Saikali, Marietta Franco, Stefan Hemmerich, Kin-Hung P. Yu, Thomas B. Neff

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study

    A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study by Chaim Charytan, Roberto Manllo-Karim, Edouard Martin, Dylan Steer, Marializa Bernardo, Sohan Dua, Moustafa A. Moustafa, Gopal Saha, Charles W. Bradley, Meraf Eyassu, Robert Leong, Khalil G. Saikali, Cameron Liu, Lynda A. Szczech, Kin-Hung P. Yu

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD

    Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD by Robert Provenzano, Anatole Besarab, Chao Sun, Susan A. Diamond, John H. Durham, José L. Cangiano, Joseph R. Aiello, James E. Novak, Tyson Lee, Robert Leong, Brian K. Roberts, Khalil G. Saikali, Stefan Hemmerich, Lynda A. Szczech, Kin-Hung P. Yu, Thomas B. Neff

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Roxadustat for CKD-related Anemia in Non-dialysis Patients

    Roxadustat for CKD-related Anemia in Non-dialysis Patients by Daniel W. Coyne, Simon D. Roger, Sug Kyun Shin, Sung Gyun Kim, Andrés Cadena, Moustafa A. Moustafa, Tak Mao Chan, Anatole Besarab, Willis Chou, Charles W. Bradley, Meraf Eyassu, Robert Leong, Tyson T. Lee, Khalil G. Saikali, Lynda A. Szczech, Kin-Hung P. Yu

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China

    Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China by Nan Chen, Jiaqi Qian, Jianghua Chen, Xueqing Yu, Changlin Mei, Chuan‐Ming Hao, Gengru Jiang, Hongli Lin, Xinzhou Zhang, Li Zuo, Qiang He, Ping Fu, Xuemei Li, Dalvin Ni, Stefan Hemmerich, Cameron Liu, Lynda A. Szczech, Anatole Besarab, Thomas B. Neff, Kin-Hung P. Yu, Frank H. Valone

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis

    Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis by Nan Chen, Chuan‐Ming Hao, Xiaomei Peng, Hongli Lin, Aiping Yin, Hao Li, Ye Tao, Xinling Liang, Zhengrong Liu, Xing Changying, Jianghua Chen, Laimin Luo, Li Zuo, Yunhua Liao, Bi‐Cheng Liu, Robert Leong, Chunrong Wang, Cameron Liu, Thomas B. Neff, Lynda A. Szczech, Kin-Hung P. Yu

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis

    Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis by Nan Chen, Chuan‐Ming Hao, Bi‐Cheng Liu, Hongli Lin, Caili Wang, Changying Xing, Xinling Liang, Gengru Jiang, Zhengrong Liu, Xuemei Li, Li Zuo, Laimin Luo, Jianqin Wang, Minghui Zhao, Zhihong Liu, Guangyan Cai, Hao Li, Robert Leong, Chunrong Wang, Cameron Liu, Thomas B. Neff, Lynda A. Szczech, Kin-Hung P. Yu

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: